About Careers Internship MedBlog Contact us

Cholesterol Lowering Statins Cut Down Stroke Risk by 30% in Elders Over 75 Years

by Julia Samuel on May 20, 2015 at 10:26 AM
Font : A-A+

Cholesterol Lowering Statins Cut Down Stroke Risk by 30% in Elders Over 75 Years

Statins and fibrates reduce the risk of stroke by a third in the elderly proves the findings of a new study and it recommends that millions of people should be given these wonder drugs.

Experts say there is clear evidence that even among the over 75s, a group not routinely prescribed cholesterol-busting statins, people can benefit from the life-saving drugs.


Lead researcher Christopher Tzourio, University of Bordeaux and Inserm said that one-third reduction in stroke risk, if confirmed, could have an important effect on public health.

The research found the drugs are associated with a 30% lower stroke risk in healthy older adults, suggesting the drugs should now be considered for preventing stroke in older people as well.

The pills had traditionally been offered to people with a 20 percent risk of developing cardiovascular disease within 10 years, but the new advice said this threshold be lowered to include people with just a 10 percent risk.

The researchers concluded that their study results suggest that cholesterol-lowering drugs could be considered for the prevention of stroke in older populations previously denied access to the drugs.

They wrote that their results raise the hypothesis of protection against stroke related to long-term use of lipid (blood fat) lowering drugs for primary prevention in older people.

There have been suggestions that statins can cause worrying side effects, but experts have slammed claims of "over-medicalising" the nation insisting that the benefits of the drugs far outweigh the risks.

Source: Medindia


Recommended Readings

Latest Drug News

AstraZeneca's Liver Cancer Drug Approved by CDSCO in India
The CDSCO has approved the intravenous administration of AstraZeneca Pharma India's liver cancer drug, Tremelimumab Concentrate.
 FDA Issues Warning About Compounded Diabetes Drug Semaglutide Products
The FDA advises consumers not to use compounded medications as an alternative to known diabetic and weight reduction medications Ozempic, Rybelsus, and Wegovy.
 Parkinson's Unmet Needs Creates Path for New Entrants into the Market
Addressing the unmet needs of Parkinson's Disease by providing disease-modifying therapies could bring about a major shift in the way that patients are treated.
How Microrobots Could Help Treat Bladder Diseases?
Microrobots could swirl through a person's blood stream, search for targeted areas to treat for various ailments.
How Can Multivitamin Supplements Slow Cognitive Aging?
Supplementation with multivitamins is an inexpensive way for older adults to slow down memory loss.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Cholesterol Lowering Statins Cut Down Stroke Risk by 30% in Elders Over 75 Years Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests